Diabetic Medicine · 1999 · 126 citations · 15 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyDiabetologyPharmaceutical CareDiabetes ManagementDiabetes MellitusDiabetes PharmacotherapyGlycemic ControlHypoglycemia ManagementMedication UseAntidiabetic Drug TherapyDiabetes Medication UseHypoglycemia In DiabetesMedian AgeOral Antidiabetic MedicationsOral Antidiabetic TherapyOral Hypoglycemic ManagementOral Hypoglycemic Therapy
AIMS: A comparison of the frequency of severe hypoglycaemia leading to hospital admission in people with Type 2 diabetes mellitus (DM) treated with long vs. short-acting sulphonylureas. METHODS: A community based study over a 12-year period in the population of the city of Basle, Switzerland. The number of diabetic patients treated with oral hypoglycaemic agents was established on the basis of tablet consumption and a defined daily dose, e.g. 7.5 mg for glibenclamide, and 50 mg for glibornuride. RESULTS: Twenty-eight Type 2 diabetic patients were admitted for severe hypoglycaemia, with a median age of 73 years. There were no deaths. Sixteen of these admissions were patients treated with long-acting sulphonylureas and 12 were patients treated with short-acting forms. Only 23.5% of the population with Type 2 DM in Basle were treated with long-acting sulphonylureas. With 30345 person-years of observation, the incidence of severe hypoglycaemia was 2.24 per 1000 person-years for long-acting sulphonylureas vs. 0.75 per 1000 person-year for short-acting forms, odds ratio 3.01 (95% confidence interval 1.35-6.77). Decreased food intake (nine patients) was a major contributing factor. CONCLUSIONS: Severe hypoglycaemia leading to hospital admission is more common in elderly Type 2 diabetic patients treated with long-acting compared to short-acting sulphonylureas. Such long-acting sulphonylureas should be avoided.
15
Insulin transport across capillaries is rate limiting for insulin action in dogs.
Yan Yang, I D Hope, Marilyn Ader et al. · Journal of Clinical Investigation · 1989 · 306 citations · Full text
Hypoglycemia: Causes, neurological manifestations, and outcome
Renée Malouf, John C.M. Brust · Annals of Neurology · 1985 · 290 citations
Medicine, Neurology, Neuroscience +12
Glibenclamide-associated hypoglycaemia: A report on 57 cases
Kjell Asplund, B.‐E. Wiholm, Folke Lithner · Diabetologia · 1983 · 258 citations · Full text